HOHA Lactone Is a Key Player in the Pathogenesis of Age-Related Macular Degeneration
James Davis
Introduction. Age-related Macular Degeneration (AMD) is one of the leading causes of severe, irreversible vision impairment, affecting an estimated 200 million people globally2,4. It is a late-onset disease that causes loss of central vision by damaging the macular region of the retina2. Though the etiology of AMD is not fully understood, studies have described many risk factors and biomarkers for AMD, leading to further investigation of oxidation and complement activation as mechanisms involved in the pathogenesis of the disease1,3,4. Researchers have found HOHA Lactone to be an important molecule involved in AMD5,6,7. Researchers have also made promising advancements toward stem-cell therapy as a potential treatment for AMD. Methods. Researchers used DHA-enriched erythrocyte ghost cells and measured levels of CEP-PC-dipeptide vs CEP-dipeptide produced upon exposure to oxidizing agents6. Another study measured levels of HOHA Lactone production when DHA-enriched RPE cell cultures were exposed to UV, blue light, and white light radiation5. The same study also used MitoClick and JC-10 assays to measure changes in mitochondrial membrane potentials in RPE cells exposed to HOHA Lactone5. Another study measured levels of complement protein expression in RPE cells exposed to varying levels of HOHA Lactone7. In another study, researchers used CD34+ peripheral blood cells and generated RPE cells from IPSCs8. They used a biodegradable scaffold to transplant their iRPE cell patch into a pig AMD model and took observations via OCT8. Results. In DHA-PC oxidation, HOHA-PC primarily deacylates to form HOHA Lactone as a stable intermediate6. Light radiation was found to increase DHA oxidation to form HOHA Lactone products (UV light > blue light > white light > dark)5. RPE cells exposed to HOHA Lactone showed measurable changes in mitochondrial membrane potential5. RPE cells exposed to HOHA Lactone also showed increased complement protein expression7. The iRPE cell patch with a biodegradable scaffold showed better grafting into a pig AMD model8. Conclusions. Studies have found light radiation may be an early step in AMD pathogenesis5. Lipid oxidation in AMD produces HOHA Lactone as a stable intermediate with toxic effects on RPE cells5,6,7. HOHA Lactone causes damage to mitochondrial membranes and induces complement activation/MAC formation on RPE cells, both leading to cell death6,7. Improved manufacturing techniques for RPE cell lines, better graft scaffolds, and evidence of RPE cell rescue with iRPE grafts in AMD models show promising steps forward in stem cell therapy as a potentially effective treatment for AMD patients8.
- Zajac-Pytrus, H. M., et al. (2015). “The Dry Form of Age-Related Macular Degeneration (AMD): The Current Concepts of Pathogenesis and Prospects for Treatment.” Adv Clin Exp Med 24(6): 1099-1104.
- Mitchell, P., et al. (2018). “Age-related macular degeneration.” Lancet 392(10153): 1147-1159.
- Lambert, N. G., et al. (2016). “Risk factors and biomarkers of age-related macular degeneration.” Prog Retin Eye Res 54: 64-102.
- Oner, A., et al. (2018). “Suprachoroidal Adipose Tissue-Derived Mesenchymal Stem Cell Implantation in Patients with Dry-Type Age-Related Macular Degeneration and Stargardt’s Macular Dystrophy: 6-Month Follow-Up Results of a Phase 2 Study.” Cell Reprogram 20(6): 329-336.
- Cheng, Y. S., et al. (2019). “Light-induced generation and toxicity of docosahexaenoate-derived oxidation products in retinal pigmented epithelial cells.” Exp Eye Res 181: 325-345.
- Wang, H., et al. (2015). “4-Hydroxy-7-oxo-5-heptenoic Acid (HOHA) Lactone is a Biologically Active Precursor for the Generation of 2-(omega-Carboxyethyl)pyrrole (CEP) Derivatives of Proteins and Ethanolamine Phospholipids.” Chem Res Toxicol 28(5): 967-977.
- Linetsky, M., et al. (2018). “4-Hydroxy-7-oxo-5-heptenoic Acid Lactone Is a Potent Inducer of the Complement Pathway in Human Retinal Pigmented Epithelial Cells.” Chem Res Toxicol 31(8): 666-679.
- Sharma, R., et al. (2019). “Clinical-grade stem cell-derived retinal pigment epithelium patch rescues retinal degeneration in rodents and pigs.” Sci Transl Med 11(475).